Beat on sales but sales mix hurt profitability in Q2 We cut ‘22e-‘24e EBITDA by SEK 9m, 6m, and 4m,...
Soaring interest rates affect estimates negatively Forecast property value decline of ~10% Both hi...
Redeye is once again positively surprised by the strong gross margin (80% Act.
Redeye revisits its assessment of InDex Pharmaceuticals ahead of the blinded interim analysis of CON...
Redeye updates its sales estimate for Q3 and Q4 by ~-10% while keeping its fair value range.
Etteplan has made a EUR 253m cash offer to buy Swedish Semcon, a direct competitor.
EcoRub publicerade den 26:e augusti 2022 bolagets delårsrapport för H1-22.
Gold Town Games publicerade den 25 augusti sin delårsrapport för andra kvartalet 2022.
Cline Scientific publicerade den 26:e augusti 2022 bolagets delårsrapport för H1-22.
JS Security publicerade den 25 augusti år 2022 bolagets delårsrapport för det andra kvartalet 2022.
Redeye comments on yesterday’s H1 report from Herantis and we reiterate our view of the company.
Redeye comments on RLS Global’s Q2’22 report. The report did not have any surprises, and half-year s...
Euroafrica Digital Ventures AB publicerade den 25 augusti 2022 sin delårsrapport för andra kvartalet...
Keeps steady acquisition pace Well positioned for a tougher market Currently trading at 10-8x EV/EBI...
Tillväxt men reducerad rörelsemarginal Beijer Alma växte 29% y/y i Q2 (3% organiskt) och hade intäkt...
Rapportkommentar Q2 Corline presenterade igår en positiv Q2-rapport som visade på en stabil försäljn...
Stark tillväxt Omsättningen i Q2’22 uppgick till 35 mkr (21) vilket innebär en tillväxt om 66% varav...
Pro forma growth in line with company target Margin slightly pressured by virtual care acquisitions...
Redeye comments on Pila Pharma’s Q2 report. Highlights from the quarter include receiving ODD for XE...
Redeye comments on TH1NG’s Q2 report, which was below our expectations in terms of revenues but also...
